Halozyme Therapeutics Inc (HALO):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Halozyme Therapeutics Inc (HALO) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7273
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Halozyme Therapeutics Inc (Halozyme) is a biotechnology company that develops and commercializes novel recombinant human enzymes to provide innovative products for cancer, dermatology, diabetes and drug delivery markets. The company’s marketed product, Hylenex is an agent for drug and fluid infusion. Its pipeline products include analog insulin PH20, for the treatment of diabetes; PEGPH20, for the treatment of pancreatic cancer; and HTI-501, for the treatment of scarring, among others. Its products are based on intellectual property covering the family of human enzymes known as hyaluronidases and additional enzymes affecting the extracellular matrix. Its Enhanze technology is a novel drug delivery platform proposed to enhance the absorption and dispersion of biologics. The company has partnerships with Pfizer, Roche, Baxter and Intrexon for the development and commercialization of drugs. Halozyme is headquartered in San Diego, California, the US.

Halozyme Therapeutics Inc (HALO) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Halozyme Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Halozyme Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Halozyme Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Halozyme Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Halozyme Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Halozyme Therapeutics Inc, Medical Equipment, Deal Details 10
Partnerships 10
Halozyme Therapeutics Enters into Co-Development Agreement with Ventana Medical Systems for Cancer Treatment 10
Equity Offering 11
Halozyme Therapeutics Raises USD143.8 Million in Public Offering of Shares 11
Halozyme Therapeutics Inc – Key Competitors 13
Halozyme Therapeutics Inc – Key Employees 14
Halozyme Therapeutics Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Financial Announcements 16
Aug 08, 2018: Halozyme reports second quarter 2018 results 16
May 10, 2018: Halozyme Reports First Quarter 2018 Results 18
Feb 20, 2018: Halozyme Reports Fourth Quarter And Full-Year 2017 Results 19
Nov 07, 2017: Halozyme Reports Third Quarter 2017 Results 20
Aug 08, 2017: Halozyme Reports Second Quarter 2017 Results 22
May 09, 2017: Halozyme Reports First Quarter 2017 Financial Results 23
Feb 28, 2017: Halozyme Reports Fourth Quarter And Full Year 2016 Financial Results 25
Corporate Communications 27
Sep 05, 2018: Halozyme appoints Benjamin Hickey as Chief Commercial Officer 27
Other Significant Developments 28
Jan 09, 2018: Halozyme Projects 25 To 30 Percent ENHANZE Royalty Growth In 2018 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Halozyme Therapeutics Inc, Medical Equipment, Key Facts, 2017 2
Halozyme Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Halozyme Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Halozyme Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Halozyme Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Halozyme Therapeutics Inc, Deals By Market, 2012 to YTD 2018 8
Halozyme Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Halozyme Therapeutics Enters into Co-Development Agreement with Ventana Medical Systems for Cancer Treatment 10
Halozyme Therapeutics Raises USD143.8 Million in Public Offering of Shares 11
Halozyme Therapeutics Inc, Key Competitors 13
Halozyme Therapeutics Inc, Key Employees 14
Halozyme Therapeutics Inc, Subsidiaries 15

List of Figures
Halozyme Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Halozyme Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Halozyme Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Halozyme Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Halozyme Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Halozyme Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Halozyme Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Halozyme Therapeutics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Halozyme Therapeutics Inc (HALO):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Balt Extrusion SAS:医療機器:M&Aディール及び事業提携情報
    Summary Balt Extrusion SAS (Balt) is a medical technology company which designs, manufactures and markets interventional neuro radiology (INR) devices such as intracerebral microcatheters, extrusion tubes, vascular stents and access systems. Its product portfolio includes magic, a flow-dependant mic …
  • Arkema SA:企業のM&A・事業提携・投資動向
    Arkema SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Arkema SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Independent Electricity System Operator:企業の戦略的SWOT分析
    Independent Electricity System Operator - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • China Mobile Ltd (941):企業の財務・戦略的SWOT分析
    China Mobile Ltd (941) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Investigator Resources Ltd (IVR):企業の財務・戦略的SWOT分析
    Summary Investigator Resources Ltd (Investigator Resources), is a mining company that offers exploration and development of mineral properties. The company acquires, explores and develops precious and base metal assets in Eyre Peninsulas of South Australia. It operates projects such as Paris Silver …
  • The Blackstone Group LP:企業の戦略・SWOT・財務情報
    The Blackstone Group LP - Strategy, SWOT and Corporate Finance Report Summary The Blackstone Group LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Asian American Medical Group Ltd (AJJ):企業の財務・戦略的SWOT分析
    Asian American Medical Group Ltd (AJJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Transportadora De Gas Del Sur S.A.
    Transportadora De Gas Del Sur S.A. - Strategy, SWOT and Corporate Finance Report Summary Transportadora De Gas Del Sur S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Mah Sing Group Berhad:企業の戦略・SWOT・財務情報
    Mah Sing Group Berhad - Strategy, SWOT and Corporate Finance Report Summary Mah Sing Group Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Juvenile Diabetes Research Foundation-製薬・医療分野:企業M&A・提携分析
    Summary Juvenile Diabetes Research Foundation (JDRF) is a research organization that offers funding services for type one diabetes. The organization conducts clinical trials for curing, preventing and treating for type one diabetes and its complications; and researching new drugs for patients to man …
  • Mallinckrodt, LLC-製薬・医療分野:企業M&A・提携分析
    Summary Mallinckrodt LLC (Mallinckrodt), a subsidiary of Mallinckrodt Plc is a biophramaceutical company that develops medicines. The company manufactures, markets and distributes generic and specialty pharmaceuticals, active pharmaceutical ingredients, diagnostic imaging agents, global medical imag …
  • Greenhill & Co Inc:企業の戦略・SWOT・財務情報
    Greenhill & Co Inc - Strategy, SWOT and Corporate Finance Report Summary Greenhill & Co Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Permian Basin Royalty Trust Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Permian Basin Royalty Trust Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Permian Basin Royalty Trust (Permian Basin Royalty) is an oil and gas company that owns overriding royalty rights in mineral properties in the US. The company provides oil and gas product …
  • Gulf Power Co:発電所・企業SWOT分析
    Gulf Power Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exec …
  • DIAsource ImmunoAssays SA:企業の製品パイプライン分析2018
    Summary DIAsource ImmunoAssays SA (DIAsource), formerly BioSource Europe SA, a subsidiary of BioVendor - Laboratorni Medicina as, is a diagnostics company that develops, manufactures and markets clinical diagnostic products. The company’s products comprise immunoassays, antibodies, instruments and R …
  • CTS Corp (CTS):企業の財務・戦略的SWOT分析
    Summary CTS Corp (CTS) is a manufacturer of actuators, sensors and electronic components. The company offers products such as controls, pedals, piezoelectric sense products, sensors, switches, transducers, RFI filters, frequency control products, RF filters, specialty capacitors, specialty resistors …
  • Viridian Group Investments Ltd:企業の戦略的SWOT分析
    Viridian Group Investments Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Campbell Soup Company (CPB):企業の財務・戦略的SWOT分析
    Campbell Soup Company (CPB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Maxim Power Corp.:企業の発電所・SWOT分析2018
    Maxim Power Corp. - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Westar Energy Inc (WR):企業の財務・戦略的SWOT分析
    Westar Energy Inc (WR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆